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Objective: US guidelines recommend at least annual HIV testing
for those at risk. This analysis assessed frequency and correlates of
infrequent HIV testing and late diagnosis among black men who
have sex with men (BMSM).
Methods: HIV testing history was collected at enrollment from
participants in HPTN 061, an HIV prevention trial for at-risk US
BMSM. Two definitions of late HIV diagnosis were assessed: CD4
cell count ,200 cells per cubic millimeter or ,350 cells per cubic
millimeter at diagnosis.
Results: HPTN 061 enrolled 1553 BMSM. HIV testing questions
were completed at enrollment by 1284 (98.7%) of 1301 participants
with no previous HIV diagnosis; 272 (21.2%) reported no HIV test in
previous 12 months (infrequent testing); 155 of whom (12.1% of the
1284 with testing data) reported never testing. Infrequent HIV testing
was associated with: not seeing a medical provider in the previous
6 months (relative risk [RR]: 1.08, 95% confidence interval [CI]: 1.03
to 1.13), being unemployed (RR: 1.04, CI: 1.01 to 1.07), and having
high internalized HIV stigma (RR: 1.03, CI: 1.0 to 1.05). New HIV
diagnoses were more likely among infrequent testers compared with
men tested in the previous year (18.4% vs. 4.4%; odds ratio: 4.8, 95%
CI: 3.2 to 7.4). Among men with newly diagnosed HIV, 33 (39.3%)
had a CD4 cell count ,350 cells per cubic millimeter including 17
(20.2%) with CD4 ,200 cells per cubic millimeter.
Conclusions: Infrequent HIV testing, undiagnosed infection, and
late diagnosis were common among BMSM in this study. New HIV
diagnoses were more common among infrequent testers, under-
scoring the need for additional HIV testing and prevention efforts
among US BMSM.
Key Words: HIV, HIV testing, late HIV diagnosis, men who have
sex with men, black men, African American men
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INTRODUCTION
Men who have sex with men (MSM), particularly black
MSM (BMSM), are disproportionately affected by HIV in the
United States,1–4 and national guidelines recommend at least
annual HIV testing for MSM.5 Recent reports of high infec-
tion rates among MSM who reported testing within the pre-
vious 12 months have led to recommendations for more
frequent testing for all sexually active MSM, as often as every
3–6 months.6–10 Reports have shown that not testing at least
annually is common among MSM.11 In recent surveys from
the US Centers for Disease Control and Prevention (CDC),
38% of MSM reported not testing for HIV in the previous 12
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months6 and 17% of MSM reported that they had never been
tested for HIV.12
The disparity in HIV infection among BMSM has not
been linked to racial differences in sexual risk behavior.13–18
Potential factors reported to be driving disparities in HIV
infection among BMSM include racial differences in rates
of untreated sexually transmitted infections (STIs), HIV viral
load suppression, and assortative sexual mixing (choosing
sexual partners of the same race/ethnicity).14,17,19,20 Social
determinants such as discrimination, stigma, and poverty also
likely contribute to HIV racial disparities.18,21,22 It also has
been hypothesized that the disparity may be at least in part
attributable to the higher likelihood of BMSM being unaware
of their HIV status11,13,23–26 or being diagnosed late.1,14
Receiving an initial HIV diagnosis late in the course of
HIV disease can have serious consequences for the individ-
ual. Late initiation of antiretroviral therapy (ART) is associ-
ated with a diminished response to treatment,27 and a higher
risk for both progression to AIDS and mortality.28–32 Late
HIV diagnosis also has public health implications, since
individuals unaware of their HIV status may be more likely
to transmit HIV to others.33–35 The phenomenon of late HIV
diagnosis has a variety of names (eg, late diagnosis, late
testing, and late presentation) and definitions in the
literature.29–31,36–44 Late diagnosis and late presentation defi-
nitions have ranged from having concurrent AIDS at the time
of HIV testing43; having an initial CD4 cell count ,200 cells
per millimeter3,29,43; developing a CD4 cell count below 200
cells per cubic millimeter or AIDS within 3 months,41
1 year,30,36 or 3 years39 after HIV diagnosis; to having an
initial CD4 cell count ,350 cells per cubic millimeter at
the time of HIV diagnosis,38 or within 3 months of diagnosis.44
In 2009, the European Late Presenter Consensus Working
Group suggested a consensus definition for late presentation:
persons presenting for care with a CD4 cell count below 350
cells per cubic millimeter or presenting with an AIDS-defining
event, regardless of CD4 cell count.42 The group also pro-
posed a second category of “presentation with late disease,”
defined as persons presenting for care with a CD4 cell count
,200 cells per cubic millimeter or presenting with an AIDS-
defining event, regardless of CD4 cell count.42
Despite intensive efforts to promote routine HIV testing
in the United States, late HIV diagnosis remains com-
mon.30,37,39,41,45 Recent data revealed that approximately
38% of those diagnosed with HIV infection in the United
States developed AIDS within a year of their HIV diagnosis.39
Several factors have been associated with late diagnosis,
including black or Latino race/ethnicity, older age, and male
gender.38,39 The most commonly reported reasons for not
testing or late testing/late diagnosis include low perceived risk
of HIV and fear of HIV diagnosis.11,12,37,43,46 Structural bar-
riers, confidentiality concerns, lack of social support, and
marginalized status have been identified as additional risk
factors.12,37,47,48,49 Additional barriers to testing identified
among BMSM include medical mistrust, stigma, and fear of
discrimination.43,47,50
This study analyzed HIV testing data collected from
BMSM participants in the HIV Prevention Trials Network
BROTHERS study (HPTN 061) to assess the prevalence and
covariates of infrequent HIV testing, defined as not testing for
HIV in the 12 months before enrollment. This study also
evaluated the frequency of late HIV diagnosis among those
newly diagnosed with HIV infection and identified factors
associated with late HIV diagnosis. Understanding factors
associated with not testing and late HIV diagnosis are critical
for developing more effective HIV prevention interventions
for high-risk populations, including BMSM.
METHODS
This analysis used data collected from participants in
HPTN 061, a multisite study designed to determine the
feasibility and acceptability of a multicomponent HIV pre-
vention intervention for BMSM. Study details have been
previously described.51,52 In HPTN 061, BMSM were
recruited in 6 US cities (Atlanta, GA; Boston, MA; New
York, NY; Los Angeles, CA; San Francisco, CA; and
Washington, DC) from July 2009 to October 2010. HPTN
061 enrolled HIV-uninfected men, HIV-infected men who
reported that they were unaware of their HIV status (newly
diagnosed), and HIV-infected men who reported that they
were aware of their status (previously diagnosed); a maximum
of 10 men per study site were enrolled who reported that they
were in HIV care. Men were eligible to participate in the
study if they: self-identified as a man or were male at birth,
self-identified as black, were at least 18 years of age, reported
unprotected anal intercourse with a man in the previous
6 months, and resided in the metropolitan area where they
were recruited. At the enrollment visit, eligibility was con-
firmed and written informed consent obtained.
Participant interviews were conducted to collect demo-
graphic data (age, sexual identity, education, employment,
household income, housing, and student status) as well as
healthcare-related information (healthcare insurance coverage,
usual place of care, visits to a healthcare provider in the
previous 6 months, and unmet healthcare needs in the previous
6 months). Previous HIV testing history was obtained through
audio computer-assisted self-interview (ACASI) at baseline.
Participants who answered “No,” to the question “Have you
ever been tested for HIV?” or who reported “zero” for number
of times tested for HIV in the last year were considered to have
infrequent HIV testing. Other data collected through ACASI
included history of incarceration, sexual identity, and sexual
risk behaviors in the 6 months before enrollment, partner HIV
status, alcohol and other substance use,53 internalized homo-
phobia,54 perceived racism,55 internalized HIV stigma,56 HIV
conspiracy,57 mistrust, and symptoms of depression.58
Perceived racism was measured with 28 items (a =
0.95), such as “being treated rudely or disrespectfully”
because of “my race.”55 The extent that the event bothered
the participant was measured with a 5-point scale from “not at
all” to “extremely.” Scores were summed for participants who
answered all questions in the scale. The racism scale ranged
from 0 to 140; the variable was categorized as “never hap-
pened/low” (score ,48), “medium” (score from 48 to 94),
and “high” (score .95).
Internalized HIV stigma was measured based on a scale
developed by Sayles et al56 to capture stigma as perceived and
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experienced by the individual living with HIV. Participants
responded, using a 5-point Likert scale from “disagree
strongly” to “agree strongly” (a = 0.82), to 5 items, such
as “I am concerned that if I go to an AIDS organization
someone I know might see me.” Scores were summed for
participants answering all 5 questions. A participant was cat-
egorized as having low (score #15) or high (score .15)
internalized HIV stigma.
Conspiracy theory about HIV/AIDS was measured
with a 9-item scale adapted from Bogart and Thornburn,
which included statements such as, “There is a cure for
AIDS, but it is being withheld from the poor,” with responses
on a 5-point Likert scale from “disagree strongly” to “agree
strongly” (a = 0.92).57
Participants also were asked to respond to the state-
ment, “I trust the healthcare providers I see in my healthcare
setting,” using a 5-point Likert scale from “disagree strongly”
to “agree strongly.” Those who answered strongly disagree or
disagree were coded as having mistrust.
Participants reporting previous HIV-negative or
unknown status were offered HIV counseling and testing at
study enrollment. HIV rapid testing was conducted after
completion of interviews and pretest HIV/STI risk-reduction
counseling. Reactive rapid HIV test results were confirmed by
Western blot testing performed at a local laboratory. Quality
assurance testing was performed retrospectively at the HPTN
Laboratory Center to confirm the HIV infection status of all
study participants at enrollment. Men who were HIV infected
at enrollment and reported no previous diagnosis were
provisionally characterized as newly diagnosed. A subset of
those men had low or undetectable HIV RNA levels (,1000
copies/mL HIV RNA). Stored samples from those men were
tested for the presence of antiretroviral drugs at the end of the
study. Some of those men were reclassified as previously
diagnosed based on the detection of drugs indicative of ART.59
Univariate and multivariate logistic regression models
were used to identify the independent correlates of infrequent
HIV testing. Variables examined as possible correlates
included predefined baseline participant demographics, sex-
ual identity, previous healthcare utilization, substance use,
incarceration history, HIV risk behaviors, HIV status of
sexual partners, perceived racism, internalized homophobia,
internalized HIV stigma, HIV conspiracy, symptoms of
depression, and study site. To reduce the number of modeled
covariates and avoid overfitting the data, backward selection
was implemented using the criterion for retention in the
model of a P value less than 0.1. This analysis was performed
on all complete cases (908 observations). After reducing the
number of covariates, the model was then refit using complete
cases from only the selected variables (1127 observations).
City of recruitment was also adjusted for in the multivariate
model, despite not reaching the desired threshold of signifi-
cance during the selection procedure. Wald 95% confidence
intervals (CIs) were computed for the estimated odds ratios
(ORs) and risk ratios. All statistical analyses were performed
using SAS version 9.2 (SAS Institute, Cary, NC).
Men identified as newly diagnosed at study enrollment,
based on testing performed at study sites, had CD4 cell count
testing. Two definitions of late HIV diagnosis were used for
analysis: new HIV diagnosis with a CD4 cell count ,200
cells per cubic milliliter, and new HIV diagnosis with
a CD4 cell count ,350 cells per cubic milliliter at the time
of diagnosis. Correlates of late HIV diagnosis were assessed
by univariate analysis using Fisher exact tests. Variables
examined as possible correlates of late diagnosis were the
same as those assessed as possible correlates of infrequent
HIV testing, described above. No multivariate model was
fitted because of relatively small sample size (only 84 newly
diagnosed men had CD4 cell count data at enrollment).
RESULTS
Among 1553 BMSM participants enrolled, 252 (16%)
participants were classified as having a previous HIV
diagnosis based on self-report or information obtained by
the study sites (N = 185) or based on antiretroviral drug
testing performed at the HPTN Laboratory Center (N = 67).
Of the remaining 1301 participants with no previous HIV
diagnosis, 38 (2.9%) men either refused testing or did not
have a sample stored to confirm HIV status. Of the 1263
men tested with confirmatory HIV data, 96 (7.6%) men were
classified as newly diagnosed; 1167 (92.4%) were HIV unin-
fected at enrollment.
Baseline demographics of the 1301 HPTN 061 partic-
ipants with no previous HIV diagnosis at enrollment included
a median age of 38 years, 1.8% transgender, 8.0% Latino,
37.8% reported household incomes below US poverty level,
10.2% had unstable housing, 66.3% unemployed, and 41.7%
reported being uninsured (Table 1).
HIV Testing History
Among 1301 participants who had no previous HIV
diagnosis at enrollment, 1284 (98.7%) answered the HIV
testing history questions in the study ACASI. Infrequent
HIV testing was reported by 272 (21.2%) men, including 155
men (12.1% of the 1284) who reported never having been
tested for HIV before study enrollment. In the 6 cities in this
study, participants in Atlanta, GA, were most likely to report
not testing for HIV within the previous year (28.5%), whereas
those in Washington, DC, and Boston were least likely to
report infrequent testing (15.3% and 16.6%, respectively).
Correlates of HIV Testing and HIV
Testing Outcome
Univariate analyses identified several factors associated
with infrequent HIV testing (Table 2), including: older age,
lower household income, being unemployed, unstable hous-
ing, being uninsured, not identifying as gay or homosexual,
not having seen a medical provider in the previous 6 months,
and city of residence (Atlanta, San Francisco, or Los
Angeles). Variables not associated with infrequent testing
included: country of origin, being a student, being transgen-
der, injection drug use, substance use, sexual risk behavior,
partner HIV status, incarceration history, perceived racism,
and belief in HIV conspiracy.
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By modeling the data in a multivariate framework, the
number of modeled covariates was reduced from 12 signif-
icant associations (P , 0.10) in the univariate case to 4 in
the multivariate case, including an adjustment for study site
(Table 3). We identified 4 covariates of interest: employ-
ment status, housing status, internalized HIV stigma, and
seeing a healthcare provider in the last 6 months. Because
the outcome cannot be considered a rare event, the inter-
pretation of the OR in this setting does not reflect the rel-
ative probability of an individual not adhering to testing
guidelines. Therefore, risk ratios were used to quantify this
probability. In multivariate testing, 3 variables were inde-
pendently associated with infrequent HIV testing at the
0.05 level: not seeing a medical provider in the previous
6 months (relative risk [RR]: 1.08, 95% CI: 1.03 to 1.13),
being unemployed (RR: 1.04, CI: 1.01 to 1.07), and having
high levels of internalized HIV stigma (RR: 1.03, CI: 1.00
to 1.05). Although the association with housing status was
not significant at the 0.05 level, it was included in the final
multivariate model because it improved the overall fit of
the model.
Fifty (18.4%) of the 272 participants with infrequent
HIV testing were newly diagnosed with HIV at study
enrollment, compared with only 45 (4.4%) of the 1012
participants who had an HIV test in the previous year
(OR: 4.8, 95% CI: 3.2 to 7.4, P , 0.0001).
Late HIV Diagnosis
Among 1301 BMSM participants with no known
previous HIV diagnosis, 96 (7.6% of the 1263 men who
agreed to testing) were found to be HIV infected at
enrollment, including 3 later identified as having acute HIV
infection at enrollment. Acute infection was defined as having
detectable HIV RNA with negative HIV antibody tests or
with positive HIV antibody tests with a negative or indeter-
minate Western blot. All 3 men had positive Western blots at
their 6-month visits. CD4 cell count data from enrollment was
available for 84 (87.5%) of the 96 men with newly diagnosed
infection. CD4 data were missing for 12 participants. In 8
cases, CD4 cell count testing was not performed because the
initial HIV rapid test was non reactive; those men (including 3
with acute HIV infection) were retrospectively identified as
HIV-infected at the HPTN Laboratory Center.60 The median
CD4 cell count for the 84 men was 404 cells per cubic mil-
liliter (interquartile range [IQR], 209–581); 33 (39.3%) had
a CD4 cell count,350 cells per cubic milliliter at enrollment,
TABLE 1. Baseline Demographics of 1301 Participants Who
Reported Having No HIV Diagnosis Before Enrolling to
HPTN 061




Median age 38 yrs
Marital status














Exclusively homosexual/gay 361/1273 (28.4)




Not Latino 1197/1301 (92.0)
Country of origin
United States 1241/1301 (95.4)
Outside United States 60/1301 (4.6)
Highest education
High school or less 686/1300 (52.8)
Some college or higher 614/1300 (47.2)
Student status
Current student 269/1301 (20.7)
Not student 1032/1301 (79.3)
Current employment status
Working currently 438/1300 (33.7)
Not working currently 862/1300 (66.3)
Housing status
Have a stable home 1168/1301 (89.8)
Do not have a stable home 133/1301 (10.2)
Household income
Less than $9,999 487/1288 (37.8)
$10,000–$49,999 641/1288 (49.8)
$50,000 or more 160/1288 (12.4)
Frequency of insufficient income
Never 568/1300 (43.7)
Once in a while 417/1300 (32.1)







Positive, new diagnosis 96/1301 (7.4)
TABLE 1. (Continued ) Baseline Demographics of 1301
Participants Who Reported Having No HIV Diagnosis Before
Enrolling to HPTN 061
Characteristic Total (N = 1301), n (%)
HIV testing history
Never tested 155/1296 (12.0)
Tested .12 mo 117/1296 (9.0)
Tested #12 mo 1012/1296 (78.1)
Tested, time unknown 12/1296 (0.9)
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including 17 (20.2%) who had a CD4 cell count ,200 cells
per cubic milliliter. In a univariate analysis of correlates of
late testing, only age over 30 years was associated with late
diagnosis using the definition of CD4 cell count ,350 cells
per cubic milliliter (47.4% vs. 22.2%; P , 0.05). Infrequent
testing was not associated with an increased risk of late diag-
nosis in this small sample. The median CD4 cell count for the
37 newly diagnosed participants who had an HIV test in the
previous year was 373 cells per cubic milliliter (IQR, 201–
499), compared with 443 cells per cubic milliliter (IQR, 247–
588) for the 46 newly diagnosed participants reporting infre-
quent testing (P = 0.35). No other variable was found to be
associated with late HIV diagnosis by either definition.
DISCUSSION
Despite US guidelines recommending at least annual
HIV testing for sexually active MSM and more frequent
testing (every 3 to 6 months) for those at higher risk, over 1 in
5 BMSM participants reported not testing in the year before
study enrollment and 12% reported never having had an
HIV test. Although testing rates among BMSM in the
current study were better than those reported previously,6,12
infrequent testing was associated with severe consequences,
namely a significantly higher frequency of newly diagnosed
HIV infection compared with that among BMSM tested in the
previous 12 months. Infrequent testing, however, was not
associated with lower CD4 cell counts or late diagnoses in
this sample. Many factors could have contributed to the lack
of difference in CD4 between groups, including the small
sample size and the possibility of men in either group being
recently infected, which could transiently reduce CD4 cell
count. Infrequent testing has the potential to result in later
presentation with more advanced disease and ongoing HIV
transmission by those unaware of their diagnoses. These find-
ings highlight the need for further expansion of HIV testing in
populations such as BMSM who are at high-risk for HIV
infection. The high prevalence of newly diagnosed infections
TABLE 2. OR and 95% CI Obtained From Univariate Analysis That Predicts the Risk of Infrequent HIV Testing (Not Having an HIV
Test in the Previous Year)
Characteristics Level n (%)
Univariate Model
POR (95% CI)
Age Older (.30) 186 (23.3) 1.41 (1.06 to 1.88) 0.0173
Younger (#30) 86 (17.7)
Household income ,$10,000 119 (24.8) 1.43 (1.09 to 1.88) 0.0101
$$10,000 148 (18.7)
Education High school graduate or less 155 (23.0) 1.25 (0.96 to 1.64) 0.1040
Some college and higher 117 (19.2)
Employment status Unemployed 205 (24.1) 1.74 (1.29 to 2.36) 0.0003
Employed 67 (15.4)
Housing status Unstable 38 (28.8) 1.59 (1.06 to 2.37) 0.0248
Stable 234 (20.3)
Health insurance Uninsured 129 (24.2) 1.35 (1.03 to 1.77) 0.0281
Insured 143 (19.1)
Gay/homosexual Yes 103 (18.6) 0.76 (0.58 to 1.00) 0.0481
No 169 (23.2)
Poppers use Yes 19 (15.2) 0.64 (0.39 to 1.07) 0.0883
No 235 (21.8)
City LA 47 (23.2) 1.67 (1.00 to 2.79) 0.0492
SF 43 (24.2) 1.77 (1.05 to 2.98) 0.0328
Atlanta 72 (28.5) 2.21 (1.37 to 3.57) 0.0012
Boston 33 (16.6) 1.10 (0.64 to 1.90) 0.7223
NY 48 (18.4) 1.25 (0.76 to 2.07) 0.3840
DC 29 (15.3)
Depression Yes 121 (23.4) 1.28 (0.97 to 1.69) 0.0862
No 130 (19.3)
See healthcare provider in last 6 mo No 134 (26.0) 1.60 (1.22 to 2.10) 0.0006
Yes 138 (18.0)
Internalized homophobia Medium/high (sum: 17–35) 129 (23.5) 1.27 (0.96 to 1.67) 0.0898
Low (sum: 7–16) 130 (19.5)
HIV stigma High (sum .16) 106 (24.1) 1.32 (0.99 to 1.76) 0.0623
Low (sum #15) 134 (19.5)
Bold values indicate characteristics with statistical significance (P , 0.05).
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among those who were tested within the previous 12 months
(over 4%) confirms the need for even more frequent testing,
as recommended by the CDC.6–10
Being unemployed, not seeing a medical provider in the
previous 6 months, and having high levels of internalized
HIV stigma were all independently associated with infrequent
HIV testing. Presumably, those who had seen a medical
provider in the previous 6 months would have had better
access to HIV testing, which may explain this finding.
Similarly, those participants who were employed may have
had better financial resources and health insurance coverage
to facilitate access to medical care and HIV testing, though
insurance status by itself was not independently associated
with HIV testing within the previous year. The recent US
Preventive Services Task Force recommendations for routine
HIV testing, rather than risk-based testing, should increase
testing rates among BMSM who may be less likely than white
MSM to disclose their sexual identity to healthcare pro-
viders.32,61,62 In addition, healthcare reform has the potential
to improve access to care and to HIV testing for populations
lacking in resources, including health insurance. HIV-related
stigma has been identified as a barrier to HIV testing in
previous studies as well.47,63 Greater outreach and prevention
efforts are likely to be needed to reach at-risk populations
such as BMSM, to increase awareness, overcome additional
barriers such as stigma, and improve HIV testing rates. Anti-
stigma social media campaigns targeting HIV-negative indi-
viduals have been suggested as one possible way to address
stigma as a barrier to HIV testing.63 The reasons for the differ-
ences seen in previous HIV testing rates between cities are
unknown, although differences in recruitment strategies
between sites may have been a contributing factor.
In this HIV prevention study conducted in 6 US cities,
there was high uptake of HIV testing among BMSM study
participants, with 97% agreeing to testing. Although this was
a select sample of men who agreed to participate in an HIV
prevention trial, the high uptake of testing suggests that
expanded testing is possible for BMSM, particularly if
recruitment and testing are conducted by trained staff focused
on reaching this community.
Overall 7.6% of the BMSM participants tested had
newly diagnosed HIV infection at enrollment. Over one-third
of those men met one of the 2 definitions for late HIV
diagnosis; 39% had a CD4 cell count ,350 cells per cubic
milliliter at diagnosis, and a subset of those (20% of those
with newly diagnosed HIV infection) had a CD4 cell count
,200 cells per cubic milliliter. Thus, 20% had concurrent
AIDS at the time of HIV diagnosis. Late diagnosis was
significantly associated with older age in this study. There
was no association between late diagnosis and infrequent
HIV testing in this study, although the sample was small with
CD4 cell count data available for only 84 participants. The
high prevalence of late diagnosis and concurrent AIDS again
underscore the urgent need for expanded HIV testing among
BMSM in the United States.
A strength of this study was the large number of
BMSM participants in HPTN 061, recruited in 6 US cities
with high HIV prevalence. One limitation of the study is that
the men were selected based on an eligibility requirement of
unprotected anal intercourse, and thus are not representative
of all BMSM in the United States, but do represent a high-risk
population. The study population also had high rates of
poverty and unemployment, which is not representative of all
BMSM populations in the United States, but is consistent
with disparities seen among populations with HIV.18,20 Being
a study of entirely BMSM with few Latino men, this study
could not assess differences in HIV testing behavior between
black MSM and MSM in other racial/ethnic groups; though
few racial differences have been seen in previous studies.20,23
Another limitation is that the study relied primarily on HIV
testing history obtained by self-report. Although HIV-testing
data were collected through ACASI, it is possible that partic-
ipants could have over-reported recent HIV testing due to
social desirability. This could potentially have contributed
to the lower than expected CD4 cell count among the group
that reported testing within the previous 12 months. Antire-
troviral drug testing was performed as a supplement to self-
report for a subset of study participants likely to be on ART,
who did not disclose knowledge of their HIV status. This
testing was performed only for men with low or undetectable
HIV RNA at enrollment, and only assessed 3 antiretroviral
drug classes (nucleoside reverse transcriptase inhibitors, non-
nucleoside reverse transcriptase inhibitors, and protease in-
hibitors).59 It is possible that some of the men classified as
TABLE 3. Multivariate Analysis of the Probability of Infrequent HIV Testing (No HIV Test in the Previous Year)
Characteristics Level N (%)
Univariate Model Multivariate Model
OR (95% CI) P OR (95% CI) P RR (95% CI)
Employment status Unemployed 205 (24.1) 1.74 (1.29 to 2.36) 0.0003 1.67 (1.19 to 2.33) 0.0028 1.04 (1.01 to 1.07)
Housing status Unstable 38 (28.8) 1.59 (1.06 to 2.37) 0.0248 1.52 (0.97 to 2.40) 0.0692 1.04 (1.00 to 1.08)
Seen healthcare provider
in last 6 mo
No 134 (26.0) 1.60 (1.22 to 2.10) 0.0006 1.60 (1.19 to 2.15) 0.0018 1.08 (1.03 to 1.13)
HIV stigma High (.16) 106 (24.1) 1.32 (0.99 to 1.76) 0.0623 1.40 (1.05 to 1.89) 0.0242 1.03 (1.00 to 1.05)
City LA 47 (23.2) 1.67 (1.00 to 2.79) 0.0492 1.22 (0.70 to 2.11) 0.6171
City SF 43 (24.2) 1.77 (1.05 to 2.98) 0.0328 1.35 (0.77 to 2.39) 0.2904
City Atlanta 72 (28.5) 2.21 (1.37 to 3.57) 0.0012 1.57 (0.93 to 2.63) 0.0220
City Boston 33 (16.6) 1.10 (0.64 to 1.90) 0.7223 0.80 (0.44 to 1.45) 0.0748
City NY 48 (18.4) 1.25 (0.76 to 2.07) 0.3840 0.98 (0.57 to 1.68) 0.3728
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newly diagnosed in this report could have been on ART
without viral suppression, or could have been taking medica-
tions in another drug class. Nondisclosure of HIV status and/
or ART use has been identified previously in other settings,
including in other HIV prevention trials and in STI clinics.64–66
Some participants in HPTN 061 also did not agree to HIV
testing or did not have samples stored for confirmation of
HIV status, and some men with HIV infection were missing
CD4 cell count data. Finally, because the current analyses
used data collected in a large HIV prevention study, it was
not possible to assess all factors or barriers potentially asso-
ciated with testing.
The findings of this study highlight the fact that
sexually active BMSM are not being tested for HIV according
to the CDC guidelines. The results also underscore the need
for expanding HIV testing and prevention efforts for this
population at significant risk of HIV infection, as recom-
mended in the US National HIV/AIDS Strategy.67 The find-
ings of this study also support recent CDC recommendations
for more frequent HIV testing in BMSM.6–10 Although the
benefits of routine HIV testing are clear, and routine HIV
testing should continue in all primary care settings,5,32 addi-
tional efforts and resources are needed to reach BMSM,
particularly those not engaged in healthcare. Further research
is needed to understand the barriers to HIV testing among
BMSM and to assess interventions that reduce stigma and
promote the uptake of HIV testing for BMSM.
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